Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1487) 1487
Book Chapter (18) 18
Dissertation (18) 18
Conference Proceeding (3) 3
Publication (3) 3
Magazine Article (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (983) 983
life sciences & biomedicine (908) 908
animals (647) 647
humans (543) 543
ganglioside gm1 (432) 432
neurosciences & neurology (417) 417
biological and medical sciences (405) 405
neurosciences (394) 394
gangliosides (348) 348
male (330) 330
gm1 (327) 327
biochemistry & molecular biology (295) 295
mice (249) 249
medical sciences (242) 242
rats (239) 239
female (234) 234
gm1 ganglioside (232) 232
g ganglioside - metabolism (216) 216
neurology (191) 191
lipids (186) 186
fundamental and applied biological sciences. psychology (180) 180
g ganglioside - pharmacology (176) 176
g ganglioside - immunology (167) 167
cell biology (148) 148
clinical neurology (142) 142
ganglioside (128) 128
cholera toxin (126) 126
adult (108) 108
cells, cultured (108) 108
middle aged (103) 103
biophysics (97) 97
immunology (96) 96
proteins (96) 96
g ganglioside - chemistry (85) 85
analysis (81) 81
vertebrates: nervous system and sense organs (79) 79
molecular sequence data (75) 75
gm1 gangliosidosis (73) 73
mice, inbred c57bl (73) 73
cholesterol (72) 72
alzheimer's disease (71) 71
gangliosidosis, gm1 - genetics (69) 69
chemistry (67) 67
mutation (67) 67
beta-galactosidase - genetics (66) 66
cell membrane - metabolism (65) 65
gangliosidosis, gm1 - metabolism (65) 65
nervous system (65) 65
rats, sprague-dawley (65) 65
aged (64) 64
cholera toxin - metabolism (64) 64
pharmacology & pharmacy (64) 64
biochemistry, general (63) 63
gangliosides - metabolism (63) 63
cholera (62) 62
enzyme-linked immunosorbent assay (61) 61
membrane microdomains - metabolism (61) 61
cell line (60) 60
physical sciences (59) 59
science & technology - other topics (59) 59
gangliosides - immunology (58) 58
guillain-barré syndrome (58) 58
immunohistochemistry (58) 58
lipid rafts (58) 58
disease models, animal (56) 56
neurons - drug effects (56) 56
neurons - metabolism (56) 56
gangliosidosis (55) 55
protein binding (55) 55
brain - metabolism (54) 54
guillain-barre syndrome (54) 54
brain (53) 53
multidisciplinary sciences (53) 53
antibodies (52) 52
biomedicine (51) 51
apoptosis (50) 50
central nervous system (50) 50
pharmacology. drug treatments (50) 50
time factors (50) 50
medicine (49) 49
research article (49) 49
biochemistry (48) 48
membranes (48) 48
multifocal motor neuropathy (48) 48
neurons (48) 48
signal transduction (48) 48
carbohydrate sequence (45) 45
life sciences (45) 45
physiological aspects (44) 44
carbohydrates (43) 43
chromatography, thin layer (43) 43
metabolic diseases (43) 43
anti-gm1 antibodies (42) 42
anti-gm1 antibody (42) 42
gangliosidosis, gm1 - pathology (42) 42
genetics & heredity (42) 42
cattle (41) 41
g ganglioside - therapeutic use (41) 41
kinetics (41) 41
enzymes (39) 39
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1463) 1463
Japanese (36) 36
Chinese (35) 35
French (11) 11
Portuguese (7) 7
Russian (4) 4
Catalan (1) 1
Czech (1) 1
Italian (1) 1
Korean (1) 1
Norwegian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Mass spectrometry imaging reveals ganglioside and ceramide localization patterns during cerebellar degeneration in the Npc1 −/− mouse model
by Tobias, Fernando and Pathmasiri, Koralege C and Cologna, Stephanie M
Analytical and bioanalytical chemistry, ISSN 1618-2642, 9/2019, Volume 411, Issue 22, pp. 5659 - 5668
Biochemistry, general | Food Science | MALDI mass spectrometry imaging | Niemann-pick disease type C | Laboratory Medicine | Cholesterol | Chemistry | Analytical Chemistry | Monitoring/Environmental Analysis | Ganglioside | Ceramide | Characterization and Evaluation of Materials | Apoptosis | Biochemistry & Molecular Biology | Physical Sciences | Life Sciences & Biomedicine | Biochemical Research Methods | Chemistry, Analytical | Science & Technology | Animals | Ceramides - metabolism | Gangliosides - metabolism | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization - methods | Mice | Chromatography, Liquid - methods | Intracellular Signaling Peptides and Proteins - genetics | Tandem Mass Spectrometry - methods | Cerebellum - pathology | Mice, Knockout | Cerebellum | Niemann-Pick disease | Pattern formation | Spectroscopy | Ions | Lipids | Mass spectroscopy | Mapping | Sphingolipids | Ganglioside GM1 | Substantia alba | Negative ions | Cell death | Neurodegeneration | Ionization | Imaging | Biomolecules | Npc1 protein | Scientific imaging | Degeneration | Localization | Mass spectrometry | Gangliosides | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text GM1 Ganglioside: Past Studies and Future Potential
by Aureli, Massimo and Aureli, Massimo and Mauri, Laura and Mauri, Laura and Ciampa, Maria Grazia and Ciampa, Maria Grazia and Prinetti, Alessandro and Prinetti, Alessandro and Toffano, Gino and Toffano, Gino and Secchieri, Cynthia and Secchieri, Cynthia and Sonnino, Sandro and Sonnino, Sandro
Molecular neurobiology, ISSN 0893-7648, 4/2016, Volume 53, Issue 3, pp. 1824 - 1842
Neurology | Neurosciences | GM1 Chemistry and Physico-chemistry | GM1 and the neurodegenerative diseases | Biomedicine | Neurobiology | GM1 | GM1 and Cholera toxin | Cellular organization of GM1 | Cell Biology | Neurotrophic and neuroprotective properties of GM1 | GM1 and GBS | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neuroprotective Agents - therapeutic use | Animals | Neuroprotective Agents - pharmacology | Cholera Toxin - metabolism | Humans | Terminology as Topic | G(M1) Ganglioside - therapeutic use | G(M1) Ganglioside - chemistry | Neurodegenerative Diseases - drug therapy | G(M1) Ganglioside - metabolism | G(M1) Ganglioside - pharmacology | Autoimmunity | Nervous system diseases | Autoantibodies | Cholera | Cholera toxin | Gangliosides | Organic acids | Brain | Biochemistry | Cellular biology | Neurons | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Aβ–ganglioside interactions in the pathogenesis of Alzheimer's disease
by Matsuzaki, Katsumi
Biochimica et biophysica acta. Biomembranes, ISSN 0005-2736, 08/2020, Volume 1862, Issue 8, pp. 183233 - 183233
Monosialoganglioside GM1 | Amyloid fibrils | Cytotoxicity | Amyloid β-protein | Alzheimer's disease | Gangliosides | Biochemistry & Molecular Biology | Biophysics | Life Sciences & Biomedicine | Science & Technology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Ganglioside metabolism and Parkinson's disease
by Forsayeth, John and Hadaczek, Piotr
Frontiers in neuroscience, ISSN 1662-4548, 02/2018, Volume 12, pp. 45 - 45
GM1 ganglioside | B4GALNT1 | Glial cell-derived neurotrophic factor | Parkinson's disease | GDNF | Alpha-synuclein | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Cellular signal transduction | Research | Lipid metabolism | Gangliosides | Enzymes | Glial cell line-derived neurotrophic factor | Basal ganglia | Neurodegenerative diseases | Neurons | Substantia nigra | Parkinsons disease | Central nervous system diseases | Ganglioside GM1 | Synuclein | Metabolism | Kinases | Studies | Proteins | Pathology | Hypotheses | Overexpression | Neostriatum | Constipation | Movement disorders | Apoptosis | alpha-synuclein | glial cell-derived neurotrophic factor
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Anti-Ganglioside Antibody Induction by Swine (A/NJ/1976/H1N1) and Other Influenza Vaccines: Insights into Vaccine-Associated Guillain-Barré Syndrome
by Nachamkin, Irving and Shadomy, Sean V and Moran, Anthony P and Cox, Nancy and Fitzgerald, Collette and Ung, Huong and Corcoran, Adrian T and Iskander, John K and Schonberger, Lawrence B and Chen, Robert T
The Journal of infectious diseases, ISSN 0022-1899, 7/2008, Volume 198, Issue 2, pp. 226 - 233
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) | Infectious diseases | Applied microbiology | Biological and medical sciences | Medical sciences | DNA, Bacterial - isolation & purification | Humans | Influenza Vaccines - adverse effects | Gangliosidosis, GM1 - immunology | Gangliosides - immunology | Mice, Inbred C3H | Hemagglutination Inhibition Tests | Animals | Campylobacter jejuni - immunology | Guillain-Barre Syndrome - immunology | Swine | Glycolipids - immunology | Polymerase Chain Reaction | Antibody Formation | Influenza A virus - immunology | Mice | Porcine Reproductive and Respiratory Syndrome - immunology | Campylobacter jejuni - genetics | Influenza vaccines | Guillain-Barre syndrome | Anti-antibodies | Physiological aspects | Development and progression | Research | Gangliosides | Identification and classification | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
by Schneider, Jay S and Aras, Radha and Williams, Courtney K and Koprich, James B and Brotchie, Jonathan M and Singh, Vikrant
Scientific reports, ISSN 2045-2322, 12/2019, Volume 9, Issue 1, pp. 8362 - 8362
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Neuroprotection | Dopamine | Parkinson's disease | Neurodegeneration | Toxicity | Substantia nigra | Neostriatum | Parkinsons disease | Ganglioside GM1 | MPTP | Synuclein | Movement disorders | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text A randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson's disease patients
by Schneider, Jay S and Gollomp, Stephen M and Sendek, Stephanie and Colcher, Amy and Cambi, Franca and Du, Wei
Journal of the neurological sciences, ISSN 0022-510X, 2012, Volume 324, Issue 1, pp. 140 - 148
Neurology | GM1 | Parkinson's disease | Treatment | Symptomatic | Ganglioside | Disease modification | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Biological and medical sciences | Medical sciences | Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases | G(M1) Ganglioside - adverse effects | Double-Blind Method | Follow-Up Studies | Humans | Middle Aged | Dopamine Agonists - therapeutic use | G(M1) Ganglioside - therapeutic use | Male | Treatment Outcome | Parkinson Disease - drug therapy | Disease Progression | Antiparkinson Agents - therapeutic use | Neuropsychological Tests | Analysis of Variance | Female | Gangliosides | Care and treatment | Index Medicus | Disease Modification | Parkinson’s disease
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights